Mucosal surface glycocalyx

The mucosal surface glycocalyx is a complex, carbohydrate-rich layer that coats the apical surface of epithelial cells in the respiratory, gastrointestinal, and urogenital tracts. It consists of membrane-bound mucins, glycoproteins, and glycolipids that form a physical and chemical barrier against pathogens and environmental insults (Cone, 2009; PubMed: 19747543). This structure plays a critical role in cell signaling, lubrication, and protection of the underlying epithelium. In diseases such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and certain cancers, the glycocalyx is often altered, leading to impaired mucosal clearance or enhanced tumor invasion (Hollingsworth & Swanson, 2004; PubMed: 15510170). While not a discrete molecular target, its components are modulated by mucolytic drugs like N-acetylcysteine and are a primary focus for mucoadhesive drug delivery systems. The phrase "and associated contaminants" is not part of a standard biological target name but typically refers to debris, bacteria, or non-specific proteins trapped within the mucus matrix, often mentioned in the context of sample preparation for microscopy (Costerton et al., 1981; PubMed: 7024454). Consequently, this entry represents a biological environment or barrier rather than a specific therapeutic target for drug discovery.

Other names

Mucus layerEpithelial glycocalyxCell coatPericiliary layer

Mucolysis via reduction of disulfide bonds in mucin polymers; Mucoadhesion via non-covalent interactions with glycocalyx components.